Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223259 · ClinicalTrials.gov registry record · NA
Educating the Educator to Reduce Risk of Dance Student Injury
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03223259: Completed NA study, sponsored by NYU Langone Health.
NCT03223259 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03223259, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
A group of dance educators will attend two dance injury prevention workshops hosted by the Harkness Center for Dance Injuries (HCDI), NYU Langone Medical Center, during which participants will learn strategies to help them train their students in safe ways and impart injury prevention information through their dance classes to their students. The educators will take pre- and post-workshop tests to assess knowledge and perceptions of dance medicine. Several weeks later, participants will take a follow-up survey to assess knowledge implementation and workshop effectiveness.
Primary Outcome
The test will ask subjects questions about their dance teaching background and ascertain their current knowledge of dance anatomy and injuries.
Interventions
- BEHAVIORAL Injury Prevention Workshops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2017-10-17 |
| Phase | NA |
What the finished NCT03223259 record still lists
NCT03223259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Injury Prevention Workshops is the first listed.
NCT03223259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03223259 about?
NCT03223259 is a clinical study titled "Educating the Educator to Reduce Risk of Dance Student Injury". A group of dance educators will attend two dance injury prevention workshops hosted by the Harkness Center for Dance Injuries (HCDI), NYU Langone Medical Center, during which participants will learn strategies to help them train their students in safe ways and impart injury prevention information th...
What is the current status of trial NCT03223259?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2017-07-17. Estimated completion is 2017-10-17.
What interventions are being tested in trial NCT03223259?
The interventions under investigation include: Injury Prevention Workshops (BEHAVIORAL).
Who is sponsoring clinical trial NCT03223259?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03223259's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI